Olfr961, part of the olfactory receptor family 1 subfamily K, is integral to the olfactory system in Mus musculus, functioning as a G-protein-coupled receptor (GPCR). These receptors are pivotal for detecting and transducing odorant molecules, leading to the perception of smell. Olfr961, like other olfactory receptors, possesses a 7-transmembrane domain structure, enabling it to interact with specific odorant molecules and initiate intracellular signaling. This mechanism is central to the olfactory system's ability to discern a wide array of scents, highlighting the importance of Olfr961 in olfactory perception.
The inhibition of Olfr961's function entails either direct or indirect approaches. Direct inhibition would involve targeting the receptor's ligand-binding domain to obstruct its interaction with odorant molecules, thereby preventing G-protein activation and the subsequent signaling pathway. This requires high specificity to avoid off-target effects on other GPCRs. Alternatively, indirect inhibition includes strategies that affect the receptor's activity through modulation of related pathways or cellular processes. This can involve altering membrane dynamics, receptor conformation, or interfering with post-translational modifications, impacting the receptor's ability to transduce signals. Additionally, targeting downstream signaling pathways that regulate receptor desensitization, internalization, or recycling can also modulate Olfr961's responsiveness. The chemicals listed in the table represent potential indirect inhibitors, each acting through distinct mechanisms, such as cytochrome P450 enzyme inhibition, modulation of neurotransmitter receptors, or alteration of G-protein coupling efficiency. Understanding the intricacies of Olfr961's function and inhibition is crucial for unraveling the complex mechanisms of olfactory transduction. The exploration of both direct and indirect inhibitory strategies provides valuable insights into the modulation of GPCR activity, particularly in the context of olfactory receptors. This knowledge not only advances our understanding of olfactory perception but also contributes to the broader field of GPCR research, which has significant implications in sensory biology and pharmacology. The study of inhibitors of Olfr961 and similar receptors aids in developing a comprehensive understanding of the molecular dynamics governing olfactory signaling and the potential for targeted modulation of these processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol, a non-selective beta-adrenergic receptor blocker, modulates GPCR signaling pathways indirectly. Its action on beta receptors can affect G-protein coupling in related GPCRs, potentially impacting Olfr961. | ||||||
Risperidone | 106266-06-2 | sc-204881 sc-204881A sc-204881B sc-204881C | 10 mg 50 mg 1 g 5 g | $174.00 $719.00 $1020.00 $2040.00 | 1 | |
Risperidone, an atypical antipsychotic, acts on various neurotransmitter receptors, including GPCRs. Its broad receptor interaction profile can lead to modulation of GPCR pathways, indirectly affecting Olfr961 activity in olfaction. | ||||||
Bisoprolol | 66722-44-9 | sc-278792 | 25 mg | $208.00 | ||
Bisoprolol, a selective beta-1 adrenergic receptor blocker, affects GPCR signaling indirectly. By blocking beta-1 receptors, it can alter G-protein coupling in related GPCRs, potentially impacting Olfr961 function. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Omeprazole, a proton pump inhibitor, can indirectly modulate GPCR activity. By affecting gastric acid secretion, it impacts the histamine-mediated modulation of GPCRs, potentially affecting Olfr961 signaling. | ||||||
Labetalol | 36894-69-6 | sc-484723 | 50 mg | $180.00 | ||
Labetalol, a mixed alpha/beta adrenergic antagonist, modulates GPCR signaling pathways. Its action on both alpha and beta receptors can indirectly affect the signaling of GPCRs like Olfr961. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine, a calcium channel blocker, can influence GPCR function indirectly. By modulating calcium influx, it affects GPCR-mediated signaling, potentially impacting receptors like Olfr961. | ||||||